AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Anthera Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
2.62K
AVG Volume
2.26K
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
01M2M3M4M15 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
18 Q10
17 Q40
17 Q30
17 Q20
17 Q10
16 Q4145K
16 Q32.06M
16 Q22.8M
16 Q13.08M
15 Q43.19M
Net Income (USD) · TTM
-60M-40M-20M015 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
18 Q1-9.86M
17 Q4-17.14M
17 Q3-20.07M
17 Q2-31.89M
17 Q1-55.51M
16 Q4-55.52M
16 Q3-49.88M
16 Q2-44.73M
16 Q1-39.29M
15 Q4-35.22M
Operating Income (USD) · TTM
-60M-40M-20M015 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
18 Q1-36.8M
17 Q4-36.43M
17 Q3-41.76M
17 Q2-50.44M
17 Q1-56.06M
16 Q4-57.18M
16 Q3-49.99M
16 Q2-44.74M
16 Q1-39.3M
15 Q4-35.24M
EBITDA (USD) · TTM
-60M-40M-20M015 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
18 Q1-36.4M
17 Q4-36.15M
17 Q3-39.89M
17 Q2-48.52M
17 Q1-54.28M
16 Q4-55.37M
16 Q3-49.7M
16 Q2-44.47M
16 Q1-38.99M
15 Q4-34.93M
Cash Flows (USD) · TTM
-60M-40M-20M015 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
18 Q1-31.95M
17 Q4-36.9M
17 Q3-42.68M
17 Q2-51.43M
17 Q1-53.31M
16 Q4-49.69M
16 Q3-47.1M
16 Q2-40.85M
16 Q1-35.07M
15 Q4-30.99M
EPS (USD) · TTM
-15-10-5015 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
18 Q1-0.47
17 Q4-2
17 Q3-3.69
17 Q2-6.42
17 Q1-10.13
16 Q4-10.74
16 Q3-9.76
16 Q2-8.91
16 Q1-8.11
15 Q4-7.99
Expenses (USD) · TTM
-20M020M40M60MR&DSG&ACapex15 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
18 Q136.8M
17 Q436.53M
17 Q341.67M
17 Q250.65M
17 Q156.93M
16 Q458.09M
16 Q353M
16 Q248.2M
16 Q142.46M
15 Q438.51M
Shares Outstanding (USD) · TTM
-8M-6M-4M-2M0Buybacks (Repurchases)Stock-Based Compensation15 Q416 Q116 Q216 Q316 Q417 Q117 Q217 Q317 Q418 Q1
ANTH Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
18 Q1-6.6M
17 Q4-4.38M
17 Q3-5.72M
17 Q2-6.14M
17 Q1-6.71M
16 Q4-6.74M
16 Q3-4.99M
16 Q2-4.92M
16 Q1-4.16M
15 Q4-3.54M
Employee Count
01020304020102011201220132014201520162017
ANTH Employee Count by quarter
PeriodEmployee Count
201721
201633
201525
201420
201325
201223
201138
201025
Free Cash Flow Yield
-150000000%-100000000%-50000000%0%med -1441430.5%Jan 25May 25Sep 25Jan 26May 26Sep 26
ANTH Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1441430.5%
Sep 26-1441430.5%
Aug 26-1441430.5%
Aug 26-1441430.5%
Aug 26-1441430.5%
Aug 26-1441430.45%
Jul 26-1441430.5%
Jul 26-1441430.5%
Jul 26-1441430.45%
Jul 26-1441430.5%
Jul 26-144143.05%
Jun 26-144143.05%
Jun 26-144143.05%
Jun 26-144143.05%
Jun 26-144143.05%
May 26-1441430.5%
May 26-1441430.5%
May 26-1441430.45%
May 26-720715.24%
May 26-1441430.5%
Apr 26-1441430.5%
Apr 26-1441430.5%
Apr 26-144143045.19%
Apr 26-144143045.19%
Mar 26-1441430.5%
Mar 26-1441430.5%
Mar 26-144143045.19%
Mar 26-1441430.5%
Feb 26-1441430.5%
Feb 26-1441430.5%
Feb 26-1441430.5%
Feb 26-1441430.5%
Jan 26-1441430.5%
Jan 26-144143045.19%
Jan 26-144143045.19%
Jan 26-1441430.5%
Jan 26-1441430.45%
Dec 25-1441430.5%
Dec 25-1441430.5%
Dec 25-1441430.5%
Dec 25-144143045.19%
Nov 25-1441430.45%
Nov 25-1441430.45%
Nov 25-1441430.5%
Nov 25-144143045.19%
Oct 25-1441430.5%
Oct 25-144143045.19%
Oct 25-1441430.5%
Oct 25-144143.05%
Oct 25-144143.05%
Sep 25-144143045.19%
Sep 25-144143045.19%
Sep 25-1441430.45%
Sep 25-1441430.5%
Aug 25-1441430.5%
Aug 25-1441430.5%
Aug 25-1441430.5%
Aug 25-1441430.45%
Aug 25-1441430.5%
Jul 25-1441430.5%
Jul 25-1441430.45%
Jul 25-1441430.5%
Jul 25-1441430.5%
Jun 25-1441430.5%
Jun 25-1441430.5%
Jun 25-1441430.45%
Jun 25-1441430.45%
May 25-1441430.45%
May 25-1441430.5%
May 25-1441430.5%
May 25-1441430.45%
May 25-1441430.5%
Apr 25-1441430.45%
Apr 25-1441430.45%
Apr 25-144143045.19%
Apr 25-1441430.5%
Mar 25-1441430.5%
Mar 25-1441430.5%
Mar 25-144143045.19%
Mar 25-720715.24%
Feb 25-720715.24%
Feb 25-720715.24%
Feb 25-144143045.19%
Feb 25-720715.24%
Jan 25-144143045.19%
Jan 25-720715.24%
Jan 25-720715.24%
Jan 25-720715.24%
Jan 25-720715.24%
Dec 24-144143045.19%
Dec 24-1441430.5%
Dec 24-1441430.5%
Dec 24-1441430.5%
Nov 24-1441430.5%
Nov 24-144143045.19%
Nov 24-1441430.5%
Nov 24-1441430.5%
Nov 24-1441430.45%
Oct 24-1441430.5%
Oct 24-1441430.5%
Price to Sales
050010001500med 48.87Oct 15Jan 16Apr 16Aug 16Nov 16Mar 17Jun 17
ANTH Price to Sales by quarter
PeriodPrice to Sales
Jun 1760.39
Jun 1767.35
Jun 1758.93
Jun 1761.49
May 1761.13
May 1759.66
May 1777.96
May 1779.43
Apr 1796.63
Apr 17121.16
Apr 17114.93
Apr 17116.03
Mar 17124.45
Mar 178.33
Mar 178.76
Mar 1713.99
Mar 1712.93
Feb 1714.02
Feb 1713.34
Feb 1712.55
Feb 1712.5
Jan 1710.81
Jan 1712.17
Jan 1713.56
Jan 1713.76
Dec 1613.11
Dec 1628.91
Dec 1627.88
Dec 1628.03
Dec 1622.01
Nov 1626.12
Nov 1626.86
Nov 1628.62
Nov 1634.49
Oct 1631.85
Oct 1639.77
Oct 1643
Oct 1646.08
Sep 1646.23
Sep 1641.41
Sep 1639.73
Sep 1638.95
Sep 1638.04
Aug 1638.56
Aug 1640.63
Aug 1639.86
Aug 1641.15
Jul 1639.98
Jul 1640.11
Jul 1642.71
Jul 1649.46
Jul 1641.28
Jun 1639.76
Jun 1637.38
Jun 1642.64
Jun 1646.91
May 1643.77
May 1645.15
May 1640.76
May 1637.88
Apr 1646.41
Apr 1653.56
Apr 1648.29
Apr 1648.16
Apr 1646.53
Mar 16107.16
Mar 16117.69
Mar 16130.08
Mar 16116.15
Feb 1693.85
Feb 1693.85
Feb 1688.58
Feb 1682.7
Jan 16100.04
Jan 16102.52
Jan 16106.54
Jan 16116.15
Dec 15143.71
Dec 15308.54
Dec 15332.69
Dec 15305.19
Dec 15340.74
Nov 15392.39
Nov 15354.82
Nov 15355.49
Nov 15407.81
Oct 15387.02
Oct 15392.39
Oct 15452.75
Oct 15410.5
Oct 15421.9
Sep 15847
Sep 151081.28
Sep 15904.44
Sep 15824.47
Aug 15834.61
Aug 15792.94
Aug 151038.48
Aug 151076.77
Jul 151228.83
Price to Book
0000.01med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ANTH Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Anthera Pharmaceuticals, Inc.
ANTH
Stockpicker

Video analysis: ANTH

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ANTH

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.